Research graph
References from Chronic Spontaneous Urticaria Endotypes: Exploratory Proteomic Analysis in the Benralizumab <scp>ARROYO</scp> Study. Local targets link to admitted publications; unresolved targets remain external evidence.
Chronic Spontaneous Urticaria: A Review
10.1001/jama.2024.15568 · 2024 · External reference
Type I and Type IIb Autoimmune Chronic Spontaneous Urticaria: Using Common Clinical Tools for Endotyping Patients With CSU
2023 · External reference
The Role of Crosstalk of Immune Cells in Pathogenesis of Chronic Spontaneous Urticaria
10.3389/fimmu.2022.879754 · 2022 · External reference
Predictors of Treatment Response in Chronic Spontaneous Urticaria
10.1111/all.14757 · 2021 · External reference
Benralizumab Does Not Elicit Therapeutic Effect in Patients With Chronic Spontaneous Urticaria: Results From the Phase 2b Multinational, Randomised, Double‐Blind, Placebo‐Controlled ARROYO Trial
10.1093/bjd/ljae067 · 2024 · External reference
MEDI‐563, a Humanized Anti‐IL‐5 Receptor Alpha mAb With Enhanced Antibody‐Dependent Cell‐Mediated Cytotoxicity Function
10.1016/j.jaci.2010.04.004 · 2010 · External reference
Gene Set Enrichment Analysis: A Knowledge‐Based Approach for Interpreting Genome‐Wide Expression Profiles
10.1073/pnas.0506580102 · 2005 · External reference
B Cell Stimulatory Factor‐1 Enhances the IgE Response of Lipopolysaccharide‐Activated B Cells
10.4049/jimmunol.136.12.4538 · 1986 · External reference
Dupilumab in Patients With Chronic Spontaneous Urticaria (LIBERTY‐CSU CUPID): Two Randomized, Double‐Blind, Placebo‐Controlled, Phase 3 Trials
10.1016/j.jaci.2024.01.028 · 2024 · External reference
